ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.00
-0.45%
Dow Jones
40,211.72
0.00%
Gold vs US Dollar
2,440.205
0.74%
Brent Oil
83.125
-1.44%
Bitcoin
63,689.63
-1.79%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onyx Pharmaceuticals, Inc. (MM) (ONXX)

  7. Onyx Pharmaceuticals, Inc. (MM) (ONXX) News

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
15/03/200721:00PR Newswire (US)Onyx Pharmaceuticals to Present at Lehman Global Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/03/200721:00PR Newswire (US)Onyx Pharmaceuticals to Present at Cowen Health Care ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
15/02/200721:00PR Newswire (US)Onyx Pharmaceuticals Reports Fourth Quarter and Year-End 2006 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/200712:00PR Newswire (US)Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on NexavarNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/200707:05PR Newswire (US)Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on NexavarNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/200707:00PR Newswire (US)Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/02/200701:01PR Newswire (US)Onyx Pharmaceuticals to Present at BIO CEO and Investor ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/02/200721:00PR Newswire (US)Onyx Pharmaceuticals Announces Fourth Quarter and Year-End 2006 Financial Results Teleconference and WebcastNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/02/200721:00PR Newswire (US)Onyx Pharmaceuticals to Present at Merrill Lynch ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
24/01/200721:00PR Newswire (US)Onyx Pharmaceuticals to Present at Wachovia Small and Mid-Cap ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/01/200722:24PR Newswire (US)Bayer and Onyx Announce Pivotal Nexavar(R) Kidney Cancer Study Published in New England Journal of MedicineNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/01/200721:00PR Newswire (US)Onyx Pharmaceuticals to Present at JPMorgan Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/12/200611:05PR Newswire (US)Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on NexavarNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
07/11/200621:00PR Newswire (US)Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2006 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/11/200617:46PR Newswire (US)Onyx Pharmaceuticals Announces Third Quarter 2006 Financial Results Teleconference and WebcastNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/10/200622:00PR Newswire (US)Onyx Pharmaceuticals to Present at BIO Investor Forum ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/09/200622:15PR Newswire (US)Onyx Secures Equity Financing CommitmentNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/08/200622:00PR Newswire (US)Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2006 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/08/200622:00PR Newswire (US)Onyx Pharmaceuticals Announces Second Quarter 2006 Financial Results Teleconference and WebcastNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
23/07/200612:00PR Newswire (US)Nexavar(R) Approved by European Commission for the Treatment of Advanced Kidney CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/07/200614:00PR Newswire (US)Nexavar Receives FDA Fast Track Designation for Skin CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
13/06/200614:00PR Newswire (US)Nexavar Receives Fast Track Designation from the FDA for Metastatic Liver CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/06/200622:00PR Newswire (US)Onyx Names Laura A. Brege Executive Vice President and Chief Business OfficerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
06/06/200622:00PR Newswire (US)Onyx Pharmaceuticals to Present at Two Upcoming Healthcare ConferencesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/06/200616:00PR Newswire (US)Updated Overall Survival Analysis Presented on Nexavar Phase III TrialNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
01/06/200622:00PR Newswire (US)Onyx Pharmaceuticals to Webcast Analyst BriefingNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
25/05/200622:00PR Newswire (US)Onyx Pharmaceuticals to Present at Friedman Billings Ramsey Growth Investor ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/05/200622:00PR Newswire (US)Onyx Pharmaceuticals to Present at Bank of America Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/05/200622:00PR Newswire (US)Onyx Pharmaceuticals Reports First Quarter 2006 Financial ResultsNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/05/200614:00PR Newswire (US)Enrollment Completed in Phase III Studies of Nexavar for Patients With Metastatic Melanoma and Liver CancerNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Your Recent History

NASDAQ
ADI
Analog Devices
NYSE
WFC-V
Wells Fargo
NYSE
MI
Marshall & Ilsley
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved